G Proteins provide signal transduction mechanisms to seven transmembrane receptors. Recent studies have indicated that the a-subunits as well as the bg-subunits of these proteins regulate several critical signaling pathways involved in cell proliferation, dierentiation and apoptosis. Of the 17 a-subunits that have been cloned, at least ten of them have been shown to couple mitogenic signaling in ®broblast cells. Activating mutations in Ga s , Ga i2 , and Ga 12 have been correlated with dierent types of tumors. In addition, the ability of the bg-subunits to activate mitogenic pathways in dierent cell-types has been de®ned. The present review brie¯y summarizes the diverse and novel signaling pathways regulated by the a-as well as the bg-subunits of G proteins in regulating cell proliferation.
Introduction
Heterotrimeric guanine nucleotide binding proteins, commonly known as G proteins, form the super-family of signal transduction proteins that provide signal coupling mechanisms to seven transmembrane receptors. The requirement of GTP for the signal coupling of glucagon receptor to adenylyl cyclase (Rodbell et al., 1971) and subsequent characterization of a GTPbinding protein identi®ed the role of G proteins in diverse signal transduction processes (Ross and Gilman, 1977; Gilman, 1987; Hepler and Gilman, 1992) . G proteins are peripherally associated with the cytoplasmic phase of the plasma membrane and are composed of monomers of a, b, and g subunits. Upon activation by an appropriate signal, the receptor interacts with the G protein and catalyzes the exchange of`bound GDP' for GTP in the a-subunit (Ga). Subsequently, the GTP-bound a-subunit and the bg-subunits (Gbg) dissociate from the receptor as well as from each other. The`active' a-subunit and the`free' bg-subunits initiate cellular responses by altering the activity of intracellular eector molecules. Meanwhile, the intrinsic GTPase activity of the Ga hydrolyzes the bound-GTP to GDP thus deactivating itself. The Ga-GDP re-associates with Gbg, possibly attenuating the bg-eector interaction as well. The re-associated Gabg-GDP heterotrimer resets itself to interact with another molecule of receptor (Hepler and Gilman, 1992) .
Although it has been known that G proteins are involved in signal transduction processes ranging from sensory perception to cell-growth regulation, their oncogenic properties have been realized only recently (Gilman, 1987; Johnson and Dhanasekaran, 1989; Dhanasekaran et al., 1995 Dhanasekaran and Vara Prasad, 1998) . Studies from several laboratories have de®ned the novel mechanisms through which G proteins regulate cell growth, dierentiation, and oncogenesis. The focus of this review is to present a brief summary of the dierent signaling pathways activated by G proteins in the regulation of cell proliferation and to discuss the possible interrelationships between these pathways.
Diversity of G protein signaling
At present, the family of heterotrimeric G proteins consists of 17 a-subunits, ®ve b-subunits, and 12 gsubunits. The b-and g-subunits are tightly associated and can be separated only upon denaturation. Although both a-and bg-subunits are involved in cell signaling, and all the three of them show heterogeneity, the heterogeneity of the a-subunit is used for the classi®cation of G proteins. Based on the sequence similarity of the a-subunits, G proteins are classi®ed into four distinct classes ± namely G s , G i , G q , and G 12 ± by grouping the a-subunits which show 50% or more identity into a class or subfamily (Strathman et al., 1989; Strathman and Simon, 1991) . Table 1 lists the members of the four dierent classes of Ga-subunits, their known receptors and eectors. Since this list grows rapidly now, only a representative number of receptors and eectors coupled to the respective G proteins are listed. While most of the a-subunits are ubiquitously expressed Kaziro et al., 1991) , a few of them such as Ga t , Ga g , and Ga 15/16 show tissue-speci®c expression indicating their more specialized signaling role. Ga t , expressed in retina and Ga g expressed in gustatory epithelial tissue are involved in visual and taste signaling mechanisms respectively (Kaziro et al., 1991 , McLaughlin et al., 1992 . Although the determinant role of Ga 15 and its human homologue a 16 in hematopoiesis are not known, the hematopoietic cell-speci®c expression of these asubunits points to the critical cell-speci®c signaling role played by them (Amatruda et al., 1991; Wilkie et al., 1991) .
The b-subunits range in molecular weight from 34 ± 36 kDa (Clapham and Neer, 1993) . Five distinct bsubunits referred as b1, b2, b3, b4 and b5 have been identi®ed (Clapham and Neer, 1993; Watson et al., 1994 Watson et al., , 1996 . While b1, b2, b3, b4 are ubiquitously expressed, b5 appears to have tissue-speci®c expres-sions present only in the retina, neuronal tissue, and platelets. Although it has been demonstrated that the b-subunits can interact with distinct eector molecules independent of the a-subunits, it is worth noting that Ga-subunits have a seminal role even in these`bsubunit regulated' pathways. The`turning on' and`o ' of these signaling pathways are still dependent on the GDP/GTP cycle and the GTPase activity of a-subunits. In addition, the receptor interaction to speci®c G proteins primarily relies on the con®guration of the asubunit of the heterotrimer. Nevertheless, the signaling role of b-subunit suggests the possibility that a single signaling event at the receptor level can activate two dierent signal transducers consisting of the a-and bgsubunits. Ga and bg, in turn, can elicit either a single potent response or two distinct responses. The gsubunits, that range in molecular weights from 8 ± 10 kDa have tissue speci®c expression pro®les. Recent biochemical as well as crystallographic analysis of the G protein heterotrimer indicates that the g-subunit physically interacts with both the a-and the b-subunit (Rahmatullah et al., 1996; Wall et al., 1995; Lambright et al., 1996) . However, it is more tightly associated with the b-subunit and thus behaves as an integral component of the b-subunit. The carboxyl-termini of gsubunits are prenylated and proposed to have a role in the membrane association of the heterotrimer (Clapham and Neer, 1993) . Although, no signaling role has been assigned to the g-subunit, its close association with the b-subunit, its greater diversity in relation to the b-subunits, its tissue speci®c expression patterns, and its speci®city in forming complex with dierent bsubunits suggest that the g-subunit may have a determinant role in bg-signaling.
Despite the presence of such heterogeneity among the G protein subunits, a certain degree of promiscuity is seen in receptor interaction to speci®c G proteins as well as G protein interaction with speci®c eector molecules. It is likely that the observed promiscuity may be due to our inability to de®ne the speci®c a-, band g-con®guration in each of these receptor-G protein or G-protein-eector interactions. In this context, it is worth noting that a total of 800 dierent abgcon®gurations are theoretically possible and it is likely that some of these con®gurations de®ne the speci®city of G protein interactions. The ®ndings that the Gbgsubunit con®guration can confer speci®city to the signaling pathways regulated by Ga o also supports this view (Kleuss et al., 1991; Kleuss et al., 1992) .
G proteins in the regulation of cell growth and dierentiation
The observation that tropic hormones activate cell proliferation and dierentiation through the cyclic AMP (cAMP)-dependent pathway suggested the possibility that G s proteins may be involved in the regulation of cell growth (Dumont et al., 1989) . Identi®cation of the GTPase-inhibitory, activating GEFs, GDIs, GAPs (?)
G proteins and cell proliferation N Dhanasekaran et al mutations of Ga s and Ga i in a subset of endocrine tumors established the oncogenic potential of the asubunits. Subsequently, these observations led to the investigation of growth altering properties of other G proteins (Gupta et al., 1992a; Pouyssegur and Seuwen, 1992; Dhanasekaran et al., 1995; Dhanasekaran and Vara Prasad, 1998) . Growth-promoting activities of dierent Ga-subunits were investigated by expressing the GTPase-de®cient mutants of dierent Ga-subunits in various cell-lines. A great tool in identifying the role of G proteins in growth-regulation is the ®broblast transformation assay which is widely used to monitor the growth promoting and transforming ability of diverse proteins (Copeland et al., 1979) . The ®broblast cell lines such as Swiss 3T3, NIH3T3 and Rat 1a cells are in a sensitive state in which the activation of growth-regulating cytoplasmic signaling pathways promotes cellular transformation. The major limitation of ®broblast transformation assays is that they depend on a single mesenchymally derived cell which is not sensitive to transformation by all genes (Hunter, 1990) . In spite of such a limitation, the Ga-transformed ®broblasts have revealed the signaling components involved in the activation of cell proliferation (Dhanasekaran and Vara Prasad, 1998) . Similar to the use of ®broblast transformation assays to de®ne the mitogenic pathway, dierent cell lines such as F9 terratocarcinoma, PC 12 pheochromocytoma and 3T3-L1 ®broblast cells have been used to identify the role of the G protein subunits in cell dierentiation. The F9 teratocarcinoma cells has been used to investigate the role of Ga i2 in the dierentiation of these cells into primitive endoderm . Expressing anti-sense RNA for Ga i2 that reduces the endogenous a i2 levels, it has been shown that the oblation of Ga i2 induced the dierentiation of F9 cells into a primitive endoderm. A similar strategy has de®ned the role of Ga 12 and Ga 13 in retinoic acid induced dierentiation of these cells . Likewise, studies using Ga santisense oligonucleotide in 3T3-L1 ®broblasts indicated that Ga s transmits a dierentiation-inhibition signal (Wang et al., 1992) . The role of Ga 16 and Ga q in inducing PC12 cell dierentiation has been also de®ned using the GTPase de®cient mutants of these a-subunits (Heasley et al., 1996) . Dierential expression of distinct a-subunits has been documented in several differentiating systems. An interesting correlation with regard to Ga 16 and Ga i2 expression is seen during DMSO-induced neutrophil dierentiation of the human myeloid cell line, HL 60. In these cells, upon DMSOinduced dierentiation, the expression of Ga 16 is reduced by 90% whereas the expression of Ga i2 increased by 160% (Amatruda et al., 1991; Wilkie et al., 1991) . These ®ndings are interesting in the light of the fact that Ga 16 is expression is restricted speci®cally to hematopoietic cells. However, whether the differential expression of these a-subunits is the cause or eect of dierentiated phenotype has not been resolved.
As an alternative to these ®broblast-based growth assays, microinjection of dierent cells with antibodies raised against speci®c a-subunit has been used to identify the growth-promoting role of the respective asubunit. Using the a i2 -antibodies, it has been shown that the microinjection of a i2 antibodies inhibited the serum-induced DNA synthesis in Balb/c3T3 cells. (LaMorte et al., 1992) . Further analyses have shown that a q -antibodies inhibited both thrombin and bradykinin stimulated DNA synthesis whereas a i2 -antibodies inhibited only the thrombin-stimulated DNA synthesis. These results indicate that activation of mitogenic pathway by thrombin receptor depends upon both Ga q and Ga i2 whereas bradykinin depends only on Ga q (LaMorte et al., 1993) . Using this approach, the role of Ga 12 in thrombin-stimulated mitogenic pathway of 1321N1 astrocytoma cells has been con®rmed (Aragay et al., 1995) .
Studies using the activated mutants of dierent asubunits in diverse cell-types have identi®ed novel mechanisms through which these a-subunits regulate cell growth and dierentiation. Of the 17 a-subunits that have been cloned to date, ten of them, Ga s , Ga i1 , Ga i2 , Ga o , Ga q , Ga 11 , Ga 16 , Ga z , Ga 12 , and Ga 13 have been shown to be involved in the regulation of cell growth. Although these studies have unequivocally indicated the role of bg-subunits in cell signaling, overexpression of bg-subunits has never been shown to activate either cell proliferation or dierentiation. In contrast, the ability of a-subunits to activate cell proliferation and subsequent oncogenic transformation of ®broblast cells supports the emerging view that the a-subunits form a new class of oncogenes.
Ga s and the gsp oncogene
The signaling pathway mediated cAMP has been found to be mitogenic in hormone-dependent endocrine tissues such adrenal cortex, thyroid, ovary, pituitary, and testes (Dumont et al., 1989; Vallar, 1996) . These cells are endowed with seven transmembrane receptors that are coupled to the adenylyl cyclase pathway through Ga s . Tropic hormones such as growth hormone releasing hormone (GHRH) and thyroid stimulating hormone (TSH) stimulate cell proliferation in pituitary and thyroid tissues respectively through their respective G s -coupled receptors. Therefore, the observation that the Ga s -mediated signaling pathway is constitutively activated in a subset of human pituitary tumors (Vallar et al., 1987) led to an intense search for the activating mutations of Ga s in endocrine tumors. Point mutations in the a s subunit involving the replacement of either arginine 201 (R201) or glutamine 227 (Q227) were identi®ed as the activating mutations involved in pituitary GH secreting tumors and thyroid hyperfunctioning adenomas (Landis et al., 1989; Lyons et al., 1990) . Accordingly, the mutationally activated form of Ga s is known as the gsp oncogene (derived from Gs protein).
To date, gsp mutations have been detected in pituitary tumors, thyroid adenomas and thyroid carcinomas. In these tumors, the activating mutations result in the constitutive activation of adenylyl cyclasecAMP-cAMP-dependent protein kinase (PKA) signaling pathway which leads to abnormal cell proliferation (Vallar, 1996) . The role of the gsp mutations in thyroid and pituitary neoplasia was investiagted using thyroidderived FRTL-5 or pituitary-derived GH3 cells (Muca and Vallar, 1994; Zieger et al., 1996; Ham et al., 1997) . Expression of gsp has been observed to stimulate the adenylyl cyclase activity followed by an increased rate of DNA synthesis independent of the mitogenic hormone, TSH. GH3 cells expressing gsp also showed a similar increase in cAMP levels along with the activation of cell proliferation (Ham et al., 1997) . It has been also shown that the persistent activation of adenylyl cyclase by expressing the A1-fragment of the cholera toxin led to an increased proliferation of FRTL-5 cells (Zieger et al., 1996) . In addition, the ®nding that the injection of these cells into nude mice resulted in the formation of tumors clearly indicated the role of cAMP in TSH-independent cell proliferation and neoplastic transformation of thyroid tissue (Muca and Vallar, 1994; Zieger et al., 1996) . The growth promoting activity of gsp was also assessed using Swiss 3T3 cells (Zachary et al., 1990) . Expression of the gsp oncogene resulted in an increase in the rate of DNA synthesis and cell proliferation that could be correlated with elevated levels of cAMP. Although the expression of gsp potentiated the mitogenic pathway of Swiss 3T3 cells, it did not lead to the transformation of these cells (Zachary et al., 1990) .
The growth promoting activity of gsp is mainly due to the constitutive activation of the adenylyl cyclase (AC) pathway. AC mediated increase in cAMP levels leads to the persistent activation of PKA resulting in the phosphorylation and subsequent activation of cAMP responsive element-binding protein (CREBP). CREBP binds to cyclic AMP responsive elements (CREs) to transactivate the transcription of speci®c primary response genes that initiate cell proliferative machinery. In the case of pituitary somatotrophs (in which gsp has been identi®ed as an oncogene), CREBP binds to the CRE located in the promoter region of the transcription factor known as growth hormone factor 1 (GHF1) and activates its transcription. Subsequently, GHF1 transcriptionally activates the expression of other growth-promoting genes. However, it should be noted here that G s stimulates proliferation only in the cells ± such as those present in endocrine tissues ± that are positively responsive to cAMP-PKA signaling pathway for their cell growth. By contrast, in other cells, Ga s appears to have a growth inhibitory eect through its negative regulation of Ras-Raf signaling pathway (Burgering et al., 1993; Graves et al., 1993; Cook and McCormick, 1993; Wu et al., 1993; Sevetson et al., 1993) . In these cell types, PKA activated by Ga s through cAMP directly phosphorylates Raf at Ser 43 and/or Ser 671 Mischak et al., 1996) thus inhibiting Raf and its downstrean MEK-ERK cascade. Thus, gsp can have two opposing eects depending on the cells in which they are expressed (Figure 1 ).
Ga i and the gip2 oncogene
Based on its sequence homology with Ga s , the analogous activating mutations of Ga i2 are R179 and Q205. Mutations in these residues have been observed in dierent forms of tumors. While R179-mutation of Ga i2 was identi®ed in ovarian sex cord stromal tumors and adrenal cortex tumors (Lyons et al., 1990) , Q205- Figure 1 Schematic model for the regulation of cell proliferation by G proteins. Stimulation of a receptor coupled to a speci®c G protein generates both a-speci®c and bg-speci®c signals as illustrated whereas the activated (GTPase-de®cient) a-subunit stimulates only the a-speci®c events (see text for details). AC, adenylyl cyclase; PKA, cyclic AMP-dependent protein kinase; PLC, phospholipase-C; DAG, diacylglycerol; IP 3 , inositol 1,4,5 trisphosphate; Pyk2, proline-rich tyrosine kinase-2; PKC, protein kinase C; PI3K, Phosphatidylinositol 3-kinase; GEF, guanine nucleotide exchange factor; GDI, guanine nucleotide dissociation inhibitor; GAP, GTPase-activating protein; PAK, p21-activated kinase; ERK, extracellular-signal regulated kinase; MEK, mitogen-activated extracellular-signal regulated kinase kinase; MEKK, MEK kinase; JNK, Jun N-terminal kinase; JNKK, Jun N-terminal kinase kinase mutation has been detected in non-functioning pituitary tumors (Tordjman et al., 1993) . These activated mutant forms of Ga i2 are denoted as gip2 oncogenes (for Gi protein-2). Unlike gsp, the overexpression of gip2 resulted in the oncogenic transformation of Rat1a cells (Pace et al., 1991; Gupta et al., 1992a,b,c) . Surprisingly, gip2 failed to transform other ®broblast cell lines such as NIH3T3 cells. Nevertheless, it has been shown that the gip2-transformed Rat1a cells can form colonies on soft agar and the injection of these cells has been shown to form tumors in athymic nude mice (Pace et al., 1991; Gupta et al., 1992a) . Consistent with these ®ndings, inactivating gip2 protooncogene function has been shown to inhibit cell growth and tumor formation (Hermouet et al., 1996a,b) . Injection of murine melanoma cells expressing the dominant negative mutant of Ga 12 (Ga i G204A) into nude mice greatly reduced the tumerigenic potential of the melanoma cells (Hermouet et al., 1996b) . When K1735-CL19 cells expressing Ga i2 G204A were injected into athymic nude mice, the tumor formation was much delayed compared to the animals injected with either control cells or cells expressing gip2. Furthermore, the tumors formed in these animals were of reduced in size. It has also been observed that the expression of Ga i2 G204A in these melanoma cells inhibited their growth by 50%. Taken together, these results suggest that the gip2 oncogene, as wells as its protooncogene Ga i2 , are involved in the onset and the propagation of many dierent forms of tumors.
The mechanism through which gip2 activates cell proliferation and oncogenesis is not fully understood. However, the ®nding that the expression of gip2 constitutively activates MEK-ERK signaling in Rat1a cells indicated that this could be the major mechanism through which gip2 regulates cell growth (Gupta et al., 1992b) . Interestingly it has been observed that gip2-mediated activation of MEK-ERK pathway is independent of functional Ras . Based on these observations, it has been proposed that the Ras-independent activation of MEK-ERK signaling pathway by gip2 is due to the inhibitory eect of gip2 on the levels of intracellular cAMP . It has been known that the expression of gip2 leads to a decrease the cAMP levels and the resultant PKA activity in Rat1a cells (Gupta et al., 1992a,b; Lowndes et al., 1991) . Since PKA is known to inhibit Raf through phosphorylation, a reduction in PKA activity can relieve its inhibitory eect of PKA and subsequently on MEK-ERK signaling pathway Dhanasekaran and Vara Prasad, 1998) . Thus, through its downregulation of AC-cAMP-PKA pathway, gip2 can upregulate MEK-ERK signaling pathway and promote cell proliferation (Figure 1) . Such a view would be consistent with the observation that the activation of ERK by gip2 is independent of Ras . The activation of MEK-ERK signaling pathway couples gip2 signaling to the transctivation of TCFs in the nucleus.
Based on the observation that the gip2 mutations activate cell proliferation, the growth regulating properties of the other members of Ga i family was investigated. The respective a-subunits were expressed in dierent ®broblasts to test their ability to transform the ®broblast cell lines. These studies have indicated that the GTPase-de®cient mutant of Ga i1 is very similar to to the gip2 oncogene in activating cell proliferation whereas the analogous activated mutant of Ga i3 is not (Hermouet et al., 1993) . Ga z and Ga o , both of which belong to the G i family of G proteins, have also been shown to activate mitogenic pathways in dierent celltypes. The expression of an activated mutant of Ga z (Ga z Q205L) has been shown to transform Swiss 3T3 cells (Wong et al., 1995) . Although the speci®c mechanism by which Ga z Q205L activates cell proliferation has not been identi®ed yet, considering the ability of Ga z in inhibiting the adenylyl cyclase activity, it is likely that the signaling pathway activated by Ga z is analogous to the ones regulated by Ga i2 . Expression of an activated mutant of Ga o (Ga o Q205L) has been shown to transform NIH3T3 cells (Kroll et al., 1992) . Although the mechanism by which Ga o Q205L regulates cell proliferation is not fully understood, protein kinase C (PKC)-dependent activation of ERK-pathway has been implicated .
Ga q , the conditional oncogene
Although the mutations in Ga q has not been observed in any tumors, the growth promoting activity of Ga q has been investigated using the activating mutation of Ga q (Ga q Q209L). While the expression of Ga q Q209L has been shown to transform NIH3T3 cells, Ga q Q209L-induced foci formation in NIH3T3 cells was conditional upon priming the transfected cells with dexamethasone . Kalinec et al., (1992) also observed a q Q209L-mediated transformation of NIH3T3 cells. While it has been demonstrated that the injection of the transformed NIH3T3 cells into athymic nude mice induced tumors by 1 week, it has also been noticed that the expression of Ga q Q209L in NIH3T3 cells caused more cell death than transformed phenotype. Expression of Ga q Q209L proved to be cytotoxic to 80% of the transfectants (Kalinec et al., 1992) . Based on these ®ndings it was proposed that the low levels of expression of Ga q Q209L transforms the ®broblasts while higher levels of expression leads to their death. Hence the growth promoting activity of Ga q appears to be conditional upon the physiological status of the cell as well as the expression levels of the activated Ga q . The observation that the expression of Ga q Q209L inhibits cell growth (Wu et al., 1992; Qian et al., 1993) , along with the ®ndings that the persistent activation of phospholipase C (PLC) by Ga 16 Q212L inhibits PDGF-and serum-stimulated growth responses in Swiss 3T3 cells by 50 ± 80%, also supports this view (Qian et al., 1994) .
Since the activated mutants of Ga q were known to activate PI-PLCb (Wu et al., 1992; Conklin et al., 1992) , the role of PLC in Ga q -mediated cell proliferation has been investigated. It has been observed that the microinjection of PLC triggers transformation in NIH3T3 cells (Smith et al., 1989) . In addition, it has been noticed that the expression of m1, m2, m5 muscarinic- (Gutkind et al., 1991) , a1b adrenergic-or 5HT 1c -receptors (Allen et al., 1991) that are known to be coupled to PLC pathways leads to NIH3T3 cell transformation. These observations suggest that the activation of PLC is involved in the mitogenic pathway regulated by Ga q . The activation of PLC leads to cleavage of phosphatidylinositols generating inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG). The diacylglycerols generated from these pathways activate PKC and PKC in turn can stimulate ERK through Raf (Zou et al., 1996; Marais et al., 1998) . Thus, in cell types such as CHO, it has been observed that Ga q can activate an ERK-mediated proliferative pathway through a PKC-dependent but Ras-independent mechanism (Figure 1) . However, in other cell types such as the rat vascular smooth muscle and NIH3T3 cells, Ga q appear to activate ERK through a novel pathway involving proline-rich tyrosine kinase-2 (Pyk2) and Ras (Lev et al., 1995; Bourne, 1995) . This pathway appears to be activated by the IP 3 generated by the activation of PLC. IP 3 increases the cellular levels of Ca 2+ levels by stimulating the intra-as well as the extracellular mobilization of Ca
2+
. The IP 3 -induced increase in Ca 2+ levels, presumably through a Ca 2+ / calmodulin-dependent kinase, stimulate the activity of Pyk2 to activate Shc through tyrosine phosphorylation. The resultant Shc-GRB2-SOS complex stimulates Ras which leads to the activation of ERK (Lev et al., 1995; Bourne, 1995) . Thus, Ga q can regulate growth through either a Ras-dependent or Ras-independent but PKCdependent ERK pathway (Figure 1 ). Either of these pathways can couple Ga q signaling to the nuclear events through the activation of TCFs or TRE-speci®c transcription factors.
Ga 12/13 : the gep oncogenes?
The observation that cta, a Drosophila gene closely related to Ga 12 and Ga 13 , is involved in Drosophila embryogenesis, gave an early indication that the G 12 class may be involved in cell growth and development (Parks and Wieschaus, 1991) . A direct role for Ga 12 in the regulation of cell proliferation rather came from an unrelated study focussed on characterizing tumorspeci®c oncogenes. In an attempt to identify the causative oncogene of soft tissue sarcoma, Aaronson and his co-workers used an expression cloning method in which the ®broblast transformation ability of the putative oncogene was used as a reporter-assay (Chan et al., 1993) . Pooled cDNA libraries from the human sinovial tumor-derived cell line, A2095 and Ewin's sarcoma cell line, RD-ES-1 were screened for the presence of the causative oncogene. This led to the identi®cation of Ga 12 as the transforming oncogene present in the tumor derived cDNA library.
NIH3T3 cells transformed by Ga 12 were characterized by their decreased doubling time, loss of saturation density of growth, and ability to form colonies on soft-agar in addition to forming tumors in athymic nude mice. Further characterization of the transforming property of Ga 12 indicated that there was no mutational change in the Ga 12 cloned from this tumor cell-line and the expression of wild-type Ga 12 itself was sucient to alter the growth properties of NIH3T3 cells (Chan et al., 1993) . Interestingly, serum starvation inhibited the transforming ability of wildtype Ga 12 suggesting serum/agonist-dependent nature of this transformation. However, the GTPase de®cient, activated mutant of Ga 12 , Ga 12 Q229L, can abrogate the need for the serum/agonist-dependency for transformation (Xu et al., 1993) . Subsequently, the serumindependent, potent transforming activities of the QLmutants of Ga 12 and Ga 13 have been demonstrated by several laboratories (Jiang et al., 1993 Vara Prasad et al., 1994; Voyna-Yasenetskaya et al., 1994) . In this context, it is signi®cant to note that the activated mutants of Ga 12 and Ga 13 are the most potent transforming a-subunits that have been tested so far. Based on these observations, Gutkind and his colleagues have designated the G12 class of a-subunits as the gep family of oncogenes since human Ga 12 was cloned as a transforming oncogene from Ewin's sarcoma expression library .
Despite their strong transforming activity (the strongest among all the a-subunits), the role of Ga 12 and Ga 13 in naturally occurring tumors is yet to be established. Nonetheless Ga 12 QL-and Ga 13 QL-transformed ®broblasts have begun to reveal the components of the signaling network involved in the regulation of cell proliferation. Although the eector molecules that physically interact with Ga 12 and Ga 13 remain to be identi®ed, recent studies have de®ned several novel mechanisms through which these asubunits can activate cell proliferation. NIH3T3 cells transformed with Ga 12 QL or Ga 13 QL indicated that conventional secondary messenger pathways involving cAMP, Ca 2+ , or IP 3 were not altered in these cells (Chan et al., 1993; Xu et al., 1993; Jiang et al., 1993 Vara Prasad et al., 1994; VoynaYasenetskaya et al., 1994) . However, speci®c sets of primary respose genes appear to be activated in Ga 12 QL-and Ga 13 QL-transformed NIH3T3 cells (Fromm et al., 1997; Vara Prasad et al., 1994) . Ga 12 QL has been shown to activate SRFs through a Rho-dependent pathway (Fromm et al., 1997) . Ga 13 QL has been shown to activate the transcription of Egr-1 a primary response gene implicated in cell proliferation as well as dierentiation . While the ERK-MAPK pathway is not signi®cantly altered in these cells, JNK, a kinase distantly related to ERK-MAPK is constitutively activated in Ga 12 QL-and Ga 13 QL-transformed and -transfected cell lines (Vara Prasad et al., 1995; Collins et al., 1996; VoynoYasnetskaya et al., 1996) . This is one of the very few instances where the constitutive activation of JNK has an anti-apoptotic eect. Ga 12 and Ga 13 are also involved in transmitting additional growth-promoting signals (Dhanasekaran and Dermott, 1996) . These include the Ras/Rac-dependent transient activation of ERK (Mitsui et al., 1997) and Rho-dependent activation of focal adhesion complex formation (Buhl et al., 1996; Hooley et al., 1996) . The observations that cell transformation by Ga 12 is dependent on both the functional Ras, Raf, Rho, and Rac supports the view that multiple signaling inputs are involved in Ga 12 -mediated cell proliferation (Mitsui et al., 1997 , Zhang et al., 1996 Tolkacheva et al., 1997) . It is worth noting that through their activation of Ras, Rac, Rho and CDC42, Ga 12/13 also stimulate other downstream events regulated by these small GTPases. It has been observed that Ga 12 can stimulate the activities of Phosphatidyl inositol 5-phosphate kinase, a Rho-dependent kinase and probably Phosphatidyl inositol 4-phosphate kinase but not Phosphatidyl inositol 3-kinase in NIH3T3 cells (Gebauer and Dhanasekaran, unpublished observations) . Furthermore, it has been shown that Ga 13 QL stimulate PLD through a Rho-dependent pathway (Plonk et al., 1998) . In addition, it has been shown that Ga 12 can activate PKC-dependent signaling pathways in other cell types Wadsworth et al., 1997) . These additional reinforcements of cell-survival signals should be contributing to the accelerated cell growth seen in cells expressing Ga 12 QL and Ga 13 QL.
How are the multiple signaling inputs generated from Ga 12/13 integrated into a cell proliferation signal? It appears that the signals from Ga 12/13 are translated into growth-promoting signals by the small GTPases Ras, Rac, and Rho. It has been reported that Ras, Rho, Rac, and CDC42 play an essential role in cell cycle progression from G1 to S phase (Aktas et al., 1997; Takuwa and Takuwa, 1997; Olson et al., 1995; Hirai et al., 1997 ). An additional role for Rac in progression from G2 to M phase has been also identi®ed (Moore et al., 1997) . Based on these observations, it is likely that Ga 12/13 activation of Ras-, Rac-, and Rho-regulated signaling mechanisms accelerate G1/S and G2/M phase cell cycle progression. The observation that Ga 12 -induced cell proliferation depends on both Ras-regulated ERK and Ras/Racregulated JNK to progress through G1 to S phase provide strong support to this view (Mitsui et al., 1997) . Moreover, it is likely Ga 12/13 -activated Rho plays additional roles. Rho is involved in the regulation of cytoskeletal rearrangements associated with cell division and proliferation (Ridley and Hall, 1992; Takai et al., 1995) . Furthermore, Rho has been known to activate speci®c SRFs through a hitherto unidenti®ed mechanism (Hill et al., 1995) . Thus activation of Rho, in addition to Ras and Rac may greatly facilitate cell growth in cells expressing Ga 12/13 . In this context, it is signi®cant to note that Ga 12 -mediated transformation of NIH3T3 cell line is dependent on Rho and Rhomediated activation of SRFs (Fromm et al., 1997) . Thus, Ga 12/13 coordinate several critical signaling events through its interactions with the Ras-and Rho-family of GTPases. These include the regulation of dierent kinase modules as well as the activation of several transcription factors such as SRFs, TCFs, Jun and ATF2.
The temporal sequence of these signaling events can be analysed using the serum/LPA-inducible transformation of NIH3T3 cells expressing wild type Ga 12 . Using this model system, it has been observed that in addition to the activation of dierent mitogenic pathways, Ga 12 mediates the inhibition of an apoptotic pathway involving p38MAPK (Dermott and Dhanasekaran, Unpublished observations). In the light of the recent observation that p38MAPK is the primary signaling module involved in the apoptotic pathways activated by serum-deprival (Kummer et al., 1997) , this ®nding, for the ®rst time demonstrates the ability of Ga 12 to inhibit an apoptotic pathway to promote cell growth. Presumably, the combination of multiple proliferative signals together with a strong antiapoptotic signal leads to the oncogenic transformation of cells expressing these a-subunits. Perhaps, the ability to activate of such multiple growth promoting signaling-inputs confers the potent oncogenic property unique to Ga 12/13 .
The mechanisms through which Ga 12 and Ga 13 transmit their signals to the respective low molecular weight GTPases are presently not known. It is likely that they stimulate speci®c guanine nucleotide exchange factors (GEFs), compete with guanine nucleotide dissociation inhibitors (GDIs), or inhibit speci®c GAPs (Dhanasekaran and Dermott, 1996) . A role for tyrsosine phosphorylation of Shc in the signal coupling between Ga 12 and Ras has been proposed in thrombinstimulated Ga 12 -mediated mitogenic pathway of astrocytoma cells (Collins et al., 1997) . A recent observation that LPA receptors can activate Tiam-1, an exchange factor for Rac through a PKC-dependent mechanism (Fleming et al., 1997) , suggests an interesting possibility that Ga 12 , which activates PKC-dependent pathway in some cell types, can stimulate Rac and possibly Rac-mediated JNK activity through PKC and Tiam-1. The observation that the activation of JNK by Ga 12 QL is PKC-dependent in HeLa cells ®ts well with this hypothesis (Tsim and Dhanasekaran, unpublished observations). Further analysis of the mitogenic pathways activated by these a-subunits and identifying the mechanism(s) through which Ga 12/13 activate dierent small GTPase and kinases may ®nally de®ne the mitogenic pathways regulated by these Gasubunits.
Although both Ga 12 and Ga 13 activate cell proliferation and induce oncogenic transformation in dierent ®broblast cell lines, Ga 12 appears to be more potent than Ga 13 in these pathways (Jiang et al., 1993; Vara Prasad et al., 1994) . This is signi®cant in light of the recent observation that the ®broblasts derived from Ga 13 7/7 mouse embryos in which both the alleles of wild-type Ga 12 were present, did not show any decrease in ligand-induced DNA synthesis or cell proliferation (Oermanns et al., 1997) . Furthermore, in some cell types, the asyncronous activation of Ga 13 activates an apoptotic pathway (Althoefer et al., 1997) . Thus, it is likely that Ga 12 is more involved in regulation of cell proliferation than Ga 13 . Our recent ®nding that Ga 12 more avidly interacts with Ras supports such a hypothesis (Wadsworth et al., 1997) . Considering the potent oncogenic property of Ga 12 , it is likely that activating mutations in Ga 12 should be highly oncogenic leading to human tumors. However, the role of the activating mutations of Ga 12 in naturally occurring human tumors remains to be established.
The bg-subunits
The unique structure of b-subunits with seven WD-40 repeats with the resultant seven propeller motif, points to an active signaling role for bg-subunits (Wall et al., 1995; Lambright et al., 1996; Sondek et al., 1996) . All of the signaling pathways regulated by the a-subunits can be equally or more potently activated by the bgsubunits (Clapham and Neer, 1993; Gutkind, 1998) . In spite of its ability to potently activate diverse signaling pathways ± the pathways used by the Ga-subunits to activate cell proliferation ± the expression of Gbg fails to activate cell proliferation. Although the overexpression of bg-subunit has not been shown to stimulate the rate of DNA synthesis or cell proliferation, bg-subunits play a major role in mediating the seven transmembrane receptor-activation of ERK and JNK pathways (Crespo et al., 1994; Coso et al., 1996) . The mechanism by which bg-subunit activate the Ras-dependent ERK pathway has been the focus of many laboratories. The ability of bg-subunits to activate PLC and hence PKC or Ca 2+ -dependent pathways suggest that bg can activate the ERK pathway through more than one mechanism Dhanasekaran and Vara Prasad, 1998; Gutkind, 1998) .
Lefkowitz and co-workers have characterized the ability of dierent con®gurations of bg-subunits to activate ERK in COS-7 cells (Hawes et al., 1995) . Results from these studies indicated that the expression of the Gb1g1, Gb1g2, Gb1g3, and Gb2g2-configurations increased the basal levels of ERK by 6 ± 10-folds while the con®gurations involving Gb3 or Gb4 failed to activate ERK. Similarly, only the Gb1g1, Gb1g2, Gb1g3, and Gb2g2 con®gurations stimulated 3 ± 4-fold increase in PI hydrolysis suggesting their activation of PI-PLC pathways (Hawes et al., 1995) . Coexpression of a dominant negative mutant of Ras along with the Gbg completely inhibited the activation of ERK without having any eect on PLC activity. Since Gbg can physically interact and activate PLC it is likely that the IP 3 -derived from the PLC pathway can increase intracellular Ca 2+ and Ca
2+
/CAMK can activate Pyk2 kinases. Pyk2 in turn, can phosphorylate Shc, leading to the activation of GRB2 and SOS. The resultant activation of Ras can lead to the activation of ERK though Raf-MEK pathway (Rocca et al., 1997) . This is consistent with the observation that the bg-activated ERK is not sensitive to PKC-inhibitors but sensitive to Ras, Raf and tyrosine kinase inhibitors (Hawes et al., 1995) . Gbg-activation of PLC can also lead to an increase in DAGs and subsequently to the activation of PKC. Therefore, at least in some cell types, Gbg should be able to activate ERK-pathway through a PKCdependent but Ras-independent pathway similar to that of Ga q . The role of Gb5 in activating mitogenic signaling is not known. Although the observation that all of the con®gurations involving Gb1 and Gb2 raises the question of speci®city in bg-signaling (Hawes et al., 1995) , perhaps, the g-subunits that were not tested in this study may have more determinant role in conferring speci®city. Recent observations that mutations of speci®c amino acid residues in the b-subunit can selectively inhibit its interactions with dierent eectors, suggesting the bg-eector speci®city at the molecular level (Yan and Gautam, 1997) .
Interestingly, the bg-subunit-activation of Ras and the subsequent activation of ERK prove to be dependent upon the non-receptor tyrosine kinase activity of Src as well as PI3K Hawes et al., 1996) . Expression of a truncated inhibitory mutant of Src has eectively been shown to block the bg-induced stimulation of Ras-mediated ERK activity. Further analyses have shown that the coupling between bg-subunit and Src is provided by a wortmannin-sensitive phosphatidyl 3-kinase (PI3K). In cells overexpressing bg-subunits, wortmannin treatment blocks the bg-induced Src-phosphorylation as well as the ERK activation . The molecular basis for the activation of src by PI3K is speculated to be phosphatidylinositol-3,4,5-trisphosphate, one of the products of PI3K . Thus the emerging view of bg-subunit regulation of ERK activity involves PI3K, Src and Ras in a linear pathway (Rocca et al., 1997) . The role of Src in activating Ras through Shc-GRB2-SOS pathway has been already established Gutkind, 1998) . The recruitment of dierent signaling proteins such as Src, Pyk2 and PI3K by bgsubunits appears to be cell type and/or receptor dependent.
G protein interactions with other signaling pathways
It is being realized that the critical signaling pathways involved in cell proliferation, dierentiation and apoptosis are stringently regulated. Often multiple signaling inputs are required to initiate and sustain the signals involved in cell proliferation. A case to the point is the activation of multiple signaling pathways by G 12 and G 13 (Dhanasekaran and Dermott, 1996) . In some cases, multiple signaling inputs can be generated by two dierent G proteins and their subunits converging towards the activation of a single mitogenic response. Experimentally, this has been shown in HEK 293 cells in which the coexpression and stimulation of G i -coupled a2A-adrenergic receptor and the G q/11 coupled a-1B adrenergic receptors, converge towards the activation of ERK pathway through dierent routes -one through Gbg-and the other through Ga q -subunits respectively (Rocca et al., 1997) . It is very much likely that such positive cooperation between dierent G proteins exists in vivo. In addition, there seems to be dynamic interactions between G protein signaling pathways and other signaling cascades in the regulation of cell proliferation. Such interactions between dierent signaling cascades are more apparent in the mitogenic pathways regulated by tyrosine kinases and G proteins. For example, epidermal growth factor is a receptor tyrosine kinase that activates PLCg and Ras-Raf-ERK pathways in diverse cell types through the activation of both tyrosine and ser/thr kinases (Chech et al., 1988; Buday and Downward, 1993) . However in hepatocytes, EGF mediated stimulation of inositol triphosphate and DAG accumulation is dependent the presence of Ga i since this pathway can be inhibited by treating the cells with pertussis toxin (Yang et al., 1993) . Similarly, a critical role for Ga i2 in insulin signaling pathway has been reported (Moxham and Malbon, 1996; . Using inducible expression of antisense RNA to Ga i2 , it has been shown that the ablation of Ga i2 leads to physiological conditions similar to those seen in noninsulin-dependent diabetes mellitus (Moxham and Malbon, 1996) de®ning a critical role for Ga i2 in insulin-receptor signaling pathway. Interestingly, tissue-speci®c expression of activated Ga i2 (Ga i2 Q205L) mimicked the actions of insulin, thus further supporting a`permissive' role for Ga i2 in insulin-receptor signaling pathway . Recently it has been shown that the stimulation of receptors for endothelin, thrombin, and LPA transactivate EGFR and this transactivation is necessary for the activation of ERK activation, fos gene expression, and DNA synthesis suggesting the critical role played by EGFR in G protein mediated signaling (Daub et al., 1996) . Such interactions between dierent Gasubunits and other signaling cascades such as those between Ga i1 and TGFbR (Kataoka et al., 1993) , Ga i and bFGFR (Sa and Fox, 1994) , Ga q and PDGFR (De Vivo and Iyengar, 1994) , Ga i2 and CSF-1R (Corre and Hermouet, 1995) , Ga 13 and IGF-1R (Liu et al., 1997) and Ga 13 and EGFR (Gohla, 1998) have been identi®ed. However, the molecular mechanisms underlying these interactions remain to be resolved.
The role of Src in Ga q and bg-mediated stimulation of ERK-module has been discussed above. In addition, it has been observed that v-Src transformed Rat-1 ®broblasts show an enhanced G q and G 11 response to endothelins (Liu et al., 1996) . An analysis of Ga q and Ga 11 in these cells indicated that they are hyperphosphorylated at the tyrosine residues and their ability to activate PLC has been greatly increased. Taken together with the role of Src in providing signal coupling between Pyk2 and Shc in Ga q as well as bg signaling pathways Gutkind, 1998 ), it appears that there is dynamic positive interaction between Src and Ga q/11 (Liu et al., 1996) . It has been proposed that the tyrosine-phosphorylation of Ga q/11 plays a role in their interactions with their receptors (Umemori et al., 1997) . In this context, it is noteworthy that Ga s as well as Ga i can also be phosphorylated in vitro by Src (Hausdor et al., 1992) . In these studies, it has been observed that the immunoprecipitated Src preferentially phosphorylates the puri®ed Ga s and Ga i in an immunecomplex kinase assay. Although the tyrosine-phosphorylation of Ga-GDP slightly enhanced its anity for GTPgS in these studies, the signi®cance of these phosphorylations yet to be determined. In contrast, the phosphorylation of Ga z , and Ga 12 by PKC have been shown to reduce the anity of these a-subunits to bg (Fields and Casey, 1995; Kozasa and Gilman, 1996) . Interestingly, Ga 12 and Ga 13 have been shown to be rapidly phosphorylated in response to thrombin-or thromboxane A2 in a PKC dependent manner (Oermanns et al., 1996) . Although these studies propose a regulatory role for PKC in G protein signaling, the functional signi®cance of these phosphorylations remains to be established.
G proteins have been also implicated in the tyrosinephosphorylation and subsequent activation of the STAT-family of transcription factors (Bhat et al., 1994; Marrero et al., 1997) . It has been observed that the stimulation of the AT 1 -Angiotensin II receptor that primarily couples through G q results in the phosphorylation of STAT-1 and STAT-3 through a JAK2-mediated mechanism. In this context, it is worth noting that recent studies have indicated that Src family of kinases and not the Janus kinases (JAKs) activate STATs (Chaturvedi et al., 1998) . Considering the critical role of Src in transmitting the signals from both Ga q and bg to Ras pathway, it is conceivable that AT 1 -Angiotensin II receptor-stimulated Ga q and Gbg utilize Src to activate the STATs. This tantalizing link remains to be established. Similarly, the functional signi®cance of the ability of Ga q to stimulate the novel Bruton's tyrosine kinase remains to be established (Bence et al., 1997) . Nevertheless it is interesting to note that the cells de®cient in BTK show a blunted p38MAPK-response to Ga q -coupled receptors (Bence et al., 1997) .
In contrast to the positive interactions between G proteins and other signaling molecules, there are some instances in which these interactions led to the negative-regulation of speci®c mitogenic pathways. A case to the point is the ability of cAMP from G s signaling pathway to inhibit ERK-signaling pathway (Burgering et al., 1993; Graves et al., 1993; Cook and McCormick, 1993; Wu et al., 1993; Sevetson et al., 1993) . Recently it has been shown that during genotoxic stress, p53, the well characterized tumor suppressor, downregulates the activity of Ga q and Ga 11 through Ga q/11 -speci®c RGS protein (Buckbinder et al., 1997) , a negative regulator of G protein activity (Berman and Gilman, 1998) . Taken together, it appears that the parallel signals from dierent pathways modulate G protein signaling pathways. Either by recruiting multiple growth promoting signals or by actively canceling out the inhibitory signals, G proteins coordinate dierent signaling pathways so as to commit the cells to proliferation.
Concluding remarks
G protein signaling involves two speci®c signaling components, namely the a-and the bg-subunits. It should be noted here that the gsp, gip2, and the signaling pathways activated by the QL mutants of Ga q or Ga 12/13 are a-dependent pathways. Since the overexpression of the activated mutants of Ga does not involve a compensatory increase in the bg-subunits, the signaling pathways stimulated by GTPase-de®cient a-subunits are independent of the bg-subunits. Although the overexpression Gbg leads to the activation of ERK, JNK, and PLC pathways, Gbg fails to stimulate cell proliferation oncogenic transformation. Thus, it appears as though Ga generates an unique signaling input to activate cell proliferation. Nevertheless, it should be noted that Gbg-signaling plays a de®nitive role in the normal physiological activation of G protein coupled receptors by their eectors. Perhaps, during such receptor-activated mitogenic pathways, in the absence of the activating mutations in the Ga-subunits, dual signaling inputs from both the subunits may be required to increase the duration and the strength of speci®c mitogenic signal. Accordingly, the stimulation of Gs coupled receptor in GH3 or thyroid cells can lead to two mitogenic signaling inputs: 1, AC-cAMP-PKA signaling from Ga s and 2, Ras-Raf-MEK-ERK signaling from Gbg. Even in cell types in which Ga s is growth inhibitory, the bg-mediated ERK-signaling can bypass the inhibitory signal of Ga s (Crespo et al., 1995) .
In the case of Ga 1 bg heterotrimer, upon receptor stimulation both Ga i -GTP and Gbg-can stimulate ERK pathway through two dierent mechanisms. While Ga i can stimulate ERK through Ras-independent pathway, Gbg stimulates ERK though Ras. Similarly, in the case of Ga q bg heterotrimer, both Ga q and Gbg can activate PLC, thus strengthening the PLC-mediated mitogenic responses. Theoretically, Gbg released from Ga 12 bg and Ga 13 bg heterotrimers can activate both ERK and JNK through Ras and Rac respectively. However, the ®nding that the stimulation of wild-type Ga 12 leads to the activation of JNK with little or no activation of ERK suggests that Ga 12 somehow channelizes the Gbg-subunits to speci®c eector molecules.
Teleologically, the ability of a-and the bg-subunits of the heterotrimer to regulate similar responses may provide the optimal threshold levels of signaling strength required to initiate the mitogenic response. In contrast, the activated mutants of a-subunits, through constitutively and persistently activating the speci®c responses, may readily reach this threshold independent of the bg-subunit. Moreover, diverse signaling pathways cooperate with G protein signaling in converging towards the activation of speci®c kinases and transcription factors to initiate cell proliferation. Such dynamic cooperative signaling between G proteins and other signaling pathways ®nally de®ne the speci®c signaling network involved in cell proliferation. Further analyses of G protein signaling in relation to other signaling mechanisms should de®ne the dynamic interactions that occur in vivo between dierent signaling pathways. Now that the critical players involved in these the signaling pathways have been identi®ed, further studies should clarify the mechanism by which they interact and integrate to form a signaling network involved in the regulation of cell proliferation.
